Both full length-cholesteryl ester transfer protein and exon 9-deleted cholesteryl ester transfer protein promote triacylglycerol storage in cultured hepatocytes.

cellular lipid homeostasis cholesteryl ester transfer protein hepatocyte isoforms lipid metabolism triacylglycerol

Journal

Lipids
ISSN: 1558-9307
Titre abrégé: Lipids
Pays: United States
ID NLM: 0060450

Informations de publication

Date de publication:
01 2022
Historique:
revised: 22 11 2021
received: 15 07 2021
accepted: 23 11 2021
pubmed: 7 12 2021
medline: 28 1 2022
entrez: 6 12 2021
Statut: ppublish

Résumé

We previously reported that overexpression of full-length cholesteryl ester transfer protein (FL-CETP), but not its exon 9-deleted variant (∆E9-CETP), in an adipose cell line reduces their triacylglycerol (TAG) content. This provided mechanistic insight into several in vivo studies where FL-CETP levels are inversely correlated with adiposity. However, increased FL-CETP is also associated with elevated hepatic lipids, suggesting that the effect of CETP on cellular lipid metabolism may be tissue-specific. Here, we directly investigated the role of FL-CETP and ∆E9-CETP in hepatic lipid metabolism. FL- or ∆E9-CETP was overexpressed in HepG2-C3A by adenovirus transduction. Overexpression of either FL or ∆E9-CETP in hepatocytes increased cellular TAG mass by 25% but reduced TAG secretion. This cellular TAG was contained in larger and more numerous lipid droplets. Analysis of TAG synthetic and catabolic pathways showed that this elevated TAG content was due to increased incorporation of fatty acid into TAG (24%), and higher de novo synthesis of fatty acid (50%) and TAG from acetate (40%). siRNA knockdown of CETP had the opposite effect on TAG synthesis and lipogenesis, and decreased cellular TAG. This novel increase in cellular TAG by FL-CETP overexpression was reproduced in Caco-2 intestinal epithelial cells. We conclude that, unlike that seen in adipocyte cells, overexpression of either CETP isoform in lipoprotein-secreting cells promotes the accumulation of TAG. These data suggest that the in vivo correlation between CETP levels and hepatic steatosis can be explained, in part, by a direct effect of CETP on hepatocyte cellular metabolism.

Identifiants

pubmed: 34866179
doi: 10.1002/lipd.12330
pmc: PMC9060302
mid: NIHMS1773171
doi:

Substances chimiques

CETP protein, human 0
Cholesterol Ester Transfer Proteins 0
Cholesterol Esters 0
Triglycerides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-79

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL130041
Pays : United States

Informations de copyright

© 2021 AOCS.

Références

Biochem Pharmacol. 2002 Feb 1;63(3):349-60
pubmed: 11853686
Biochem Biophys Res Commun. 1994 Dec 15;205(2):1257-63
pubmed: 7802658
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):706-15
pubmed: 16439711
J Biol Chem. 2001 Jul 13;276(28):26534-41
pubmed: 11352921
Mol Cell Biochem. 1997 Dec;177(1-2):107-12
pubmed: 9450651
J Biol Chem. 1993 Aug 15;268(23):16891-4
pubmed: 8349580
Sci Rep. 2018 Aug 3;8(1):11691
pubmed: 30076407
J Biol Chem. 1981 Dec 10;256(23):11992-5
pubmed: 7298638
J Biol Chem. 1991 Mar 5;266(7):4631-9
pubmed: 1999438
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Oct;1862(10 Pt B):1166-1177
pubmed: 28627435
Biochim Biophys Acta. 1987 Oct 17;921(3):595-8
pubmed: 3117118
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11991-5
pubmed: 8876250
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1068-1081
pubmed: 29902571
IUBMB Life. 2011 Apr;63(4):248-57
pubmed: 21488146
Physiol Genomics. 2005 May 11;21(3):389-95
pubmed: 15769908
Atherosclerosis. 2008 Jan;196(1):455-460
pubmed: 17196207
J Biol Chem. 1999 Jan 22;274(4):1986-93
pubmed: 9890955
J Biol Chem. 1996 May 24;271(21):12603-9
pubmed: 8647871
J Lipid Res. 2020 Mar;61(3):422-431
pubmed: 31988147
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
Experientia. 1990 Jun 15;46(6):552-60
pubmed: 2193818
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Mar;1865(3):158583
pubmed: 31812787
J Lipid Res. 1998 Jan;39(1):173-85
pubmed: 9469596
Traffic. 2008 Mar;9(3):338-52
pubmed: 18088320
Biochemistry. 1992 Mar 3;31(8):2352-8
pubmed: 1540591
J Gastroenterol Hepatol. 2012 Sep;27(9):1520-7
pubmed: 22414273
Proteomics. 2019 May;19(10):e1700223
pubmed: 30216670
Ann Nutr Metab. 2018;73(4):265-270
pubmed: 30293065
PLoS One. 2013;8(1):e53017
pubmed: 23301014
Biochem J. 2009 May 1;419(3):629-34
pubmed: 19191759
J Lipid Res. 2015 Mar;56(3):515-525
pubmed: 25593327
Int J Obes (Lond). 2007 Oct;31(10):1586-95
pubmed: 17471296
J Lipid Res. 2021;62:100027
pubmed: 33515552
Nature. 1987 Jun 18-24;327(6123):632-4
pubmed: 3600759
PLoS One. 2014 Dec 08;9(12):e111529
pubmed: 25486007
J Biol Chem. 2011 Aug 12;286(32):28235-46
pubmed: 21680734
J Lipid Res. 1987 Apr;28(4):423-36
pubmed: 3035039
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Biol Chem. 2007 Jul 27;282(30):21856-65
pubmed: 17522050
Annu Rev Biochem. 1995;64:235-57
pubmed: 7574481
J Lipid Res. 1990 Jan;31(1):113-23
pubmed: 2313196
J Lipid Res. 2015 Sep;56(9):1669-78
pubmed: 26203075
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11437-42
pubmed: 25028495
Clin Chim Acta. 2011 Mar 18;412(7-8):587-92
pubmed: 21159313
J Lipid Res. 2019 Nov;60(11):1868-1879
pubmed: 31511396
Arteriosclerosis. 1984 May-Jun;4(3):196-207
pubmed: 6712535
Metabolism. 2021 Jan;114:154429
pubmed: 33166579
Clin Mol Hepatol. 2019 Mar;25(1):1-11
pubmed: 30086613
Biochem Biophys Res Commun. 1984 Apr 30;120(2):586-92
pubmed: 6732773
J Lipid Res. 1998 Nov;39(11):2277-85
pubmed: 9799814
Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):939-49
pubmed: 10195921
J Lipid Res. 2006 Sep;47(9):2011-9
pubmed: 16751623

Auteurs

Yan Liu (Y)

Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Daniel Mihna (D)

Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Lahoucine Izem (L)

Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Richard E Morton (RE)

Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH